Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Maximal Testosterone Suppression In Prostate Cancer - Free Vs Total Testosterone
Author: Rove K.O.
Crawford E.D.
Perachino M.
Morote J.
Klotz L.
Lange P.H.
Andriole G.L.
Matsumoto A.M.
Taneja S.S.
Eisenberger M.A.
Reis L.O.
Abstract: Testosterone remains a key target in the treatment of advanced prostate cancer. The relationship of free testosterone to prostate cancer treatment and outcomes remains largely unexplored. A consensus of prostate cancer experts was convened in 2013 to review current knowledge surrounding relationship of total and free testosterone to prostate cancer, discuss the free hormone hypothesis, and highlight future avenues for therapeutics. Free testosterone may better reflect prostate cancer tissue androgen levels than serum total testosterone concentration. Free testosterone deserves more research regarding its relation to clinical outcomes. © 2014 Elsevier Inc. All Rights Reserved.
Editor: Elsevier Inc.
Rights: fechado
Identifier DOI: 10.1016/j.urology.2014.02.001
Date Issue: 2014
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
2-s2.0-84901607422.pdf137.44 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.